Literature DB >> 25867766

Osteopontin depletion decreases inflammation and gastric epithelial proliferation during Helicobacter pylori infection in mice.

Jun Won Park1, Su Hyung Lee2, Du Min Go2, Hark Kyun Kim3, Hyo-Jung Kwon4, Dae-Yong Kim2.   

Abstract

Osteopontin (OPN) is a multifunctional protein that plays a role in many physiological and pathological processes, including inflammation and tumorigenesis. Here, we investigated the involvement of OPN in Helicobacter pylori (HP)-induced gastritis using OPN knockout (KO) mice and OPN knockdown (KD) cell lines. HP-infected OPN KO mice showed significantly reduced gastritis compared with wild-type (WT) mice with decreased infiltration of macrophages and a reduction in HP-induced upregulation of IL-1β, TNF-α, and IFN-γ. HP-exposed OPN KD gastric cancer cells and macrophage-like cells showed an attenuated induction of these cytokines. We also demonstrated a reduction in the migration of monocytic and macrophage-like cells toward conditioned media harvested from HP-exposed OPN KD gastric cancer cells as well as reduced migration ability of OPN KD cells itself. In addition, HP-infected OPN KO mice showed decreased epithelial cell proliferation compared with HP-infected WT mice, in association with a reduction in MAPK pathway activation. OPN KD gastric cancer cell lines also showed lower proliferative activity and reduced MAPK activation than shRNA control cells after HP co-culture or after IL-1β and TNF-α treatment. Taken together, these results indicate that OPN exerts a considerable influence on HP-induced gastritis by modulating the production of cytokines and contributing to macrophage infiltration. Moreover, OPN-mediated activation of the MAPK pathway in gastric epithelial cells might contribute to epithelial changes following HP infection.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25867766     DOI: 10.1038/labinvest.2015.47

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  37 in total

1.  Helicobacter pylori but not high salt induces gastric intraepithelial neoplasia in B6129 mice.

Authors:  Arlin B Rogers; Nancy S Taylor; Mark T Whary; Erinn D Stefanich; Timothy C Wang; James G Fox
Journal:  Cancer Res       Date:  2005-12-01       Impact factor: 12.701

Review 2.  Helicobacter pylori and gastric cancer: factors that modulate disease risk.

Authors:  Lydia E Wroblewski; Richard M Peek; Keith T Wilson
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

3.  Increased macrophage infiltration of gastric mucosa in Helicobacter pylori-infected children.

Authors:  A E Whitney; T S Emory; A M Marty; P A O'Shea; G W Newman; B D Gold
Journal:  Dig Dis Sci       Date:  2000-07       Impact factor: 3.199

4.  Transgenic expression of interferon-γ in mouse stomach leads to inflammation, metaplasia, and dysplasia.

Authors:  Li-Jyun Syu; Mohamad El-Zaatari; Kathryn A Eaton; Zhiping Liu; Manas Tetarbe; Theresa M Keeley; Joanna Pero; Jennifer Ferris; Dawn Wilbert; Ashley Kaatz; Xinlei Zheng; Xiotan Qiao; Marina Grachtchouk; Deborah L Gumucio; Juanita L Merchant; Linda C Samuelson; Andrzej A Dlugosz
Journal:  Am J Pathol       Date:  2012-10-01       Impact factor: 4.307

5.  Tumor necrosis factor-alpha stimulates gastric epithelial cell proliferation.

Authors:  Jiing Chyuan Luo; Vivian Yvonne Shin; Ying Hua Yang; William Ka Kei Wu; Yi Ni Ye; Wallace Hau Leung So; Full Young Chang; Chi Hin Cho
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-07-15       Impact factor: 4.052

6.  Role of tumor necrosis factor-alpha and interferon-gamma in Helicobacter pylori infection.

Authors:  Toshiro Yamamoto; Masakazu Kita; Tomoyuki Ohno; Yoichiro Iwakura; Kenji Sekikawa; Jiro Imanishi
Journal:  Microbiol Immunol       Date:  2004       Impact factor: 1.955

7.  Helicobacter pylori increases proliferation of gastric epithelial cells.

Authors:  X G Fan; D Kelleher; X J Fan; H X Xia; P W Keeling
Journal:  Gut       Date:  1996-01       Impact factor: 23.059

8.  Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro.

Authors:  S R Rittling; H N Matsumoto; M D McKee; A Nanci; X R An; K E Novick; A J Kowalski; M Noda; D T Denhardt
Journal:  J Bone Miner Res       Date:  1998-07       Impact factor: 6.741

9.  Effect of interlukin-1beta on proliferation of gastric epithelial cells in culture.

Authors:  Ian L P Beales
Journal:  BMC Gastroenterol       Date:  2002-04-05       Impact factor: 3.067

10.  The role of osteopontin in inflammatory processes.

Authors:  Susan Amanda Lund; Cecilia M Giachelli; Marta Scatena
Journal:  J Cell Commun Signal       Date:  2009-10-02       Impact factor: 5.782

View more
  5 in total

1.  Osteopontin Protects Colonic Mucosa from Dextran Sodium Sulfate-Induced Acute Colitis in Mice by Regulating Junctional Distribution of Occludin.

Authors:  Sang-Ho Woo; Su-Hyung Lee; Jun-Won Park; Du-Min Go; Dae-Yong Kim
Journal:  Dig Dis Sci       Date:  2018-08-27       Impact factor: 3.199

Review 2.  Molecular mechanisms of gastric cancer initiation and progression by Helicobacter pylori.

Authors:  Stephanie L Servetas; Dacie R Bridge; D Scott Merrell
Journal:  Curr Opin Infect Dis       Date:  2016-06       Impact factor: 4.915

3.  Integrated molecular analysis reveals complex interactions between genomic and epigenomic alterations in esophageal adenocarcinomas.

Authors:  DunFa Peng; Yan Guo; Heidi Chen; Shilin Zhao; Kay Washington; TianLing Hu; Yu Shyr; Wael El-Rifai
Journal:  Sci Rep       Date:  2017-01-19       Impact factor: 4.379

4.  Osteopontin Deficiency Suppresses Intestinal Tumor Development in Apc-Deficient Min Mice.

Authors:  Rikako Ishigamori; Masami Komiya; Shinji Takasu; Michihiro Mutoh; Toshio Imai; Mami Takahashi
Journal:  Int J Mol Sci       Date:  2017-05-14       Impact factor: 5.923

Review 5.  Stromal Protein-Mediated Immune Regulation in Digestive Cancers.

Authors:  Pia Gamradt; Christelle De La Fouchardière; Ana Hennino
Journal:  Cancers (Basel)       Date:  2021-01-05       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.